Harrow Health Inc
NASDAQ:HROW

Watchlist Manager
Harrow Health Inc Logo
Harrow Health Inc
NASDAQ:HROW
Watchlist
Price: 44.15 USD -14.77%
Market Cap: 1.6B USD
Have any thoughts about
Harrow Health Inc?
Write Note

Relative Value

The Relative Value of one HROW stock under the Base Case scenario is 41.89 USD. Compared to the current market price of 44.15 USD, Harrow Health Inc is Overvalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HROW Relative Value
Base Case
41.89 USD
Overvaluation 5%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
21
Median 3Y
4
Median 5Y
3.7
Industry
2.6
Forward
8.9
vs History
vs Industry
Median 3Y
-23
Median 5Y
-14.5
Industry
23
Forward
-121.6
vs History
0
vs Industry
3
Median 3Y
69
Median 5Y
64.4
Industry
17.8
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-11.7
Industry
25.4
vs History
11
vs Industry
4
Median 3Y
18.9
Median 5Y
11.2
Industry
2.2
vs History
0
vs Industry
18
Median 3Y
4.1
Median 5Y
3.7
Industry
2.8
Forward
9.5
vs History
0
vs Industry
19
Median 3Y
5.7
Median 5Y
5.3
Industry
5.4
vs History
0
vs Industry
1
Median 3Y
81
Median 5Y
67.6
Industry
13.7
Forward
46.2
vs History
vs Industry
0
Median 3Y
164.9
Median 5Y
41.6
Industry
17.2
Forward
326
vs History
0
vs Industry
3
Median 3Y
76.6
Median 5Y
67.1
Industry
16.5
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-5.1
Industry
19.3
vs History
25
vs Industry
17
Median 3Y
5.2
Median 5Y
6
Industry
2

Multiples Across Competitors

HROW Competitors Multiples
Harrow Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Harrow Health Inc
NASDAQ:HROW
1.8B USD 10.2 -46.7 526.5 -239.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
367.6B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
US
Harrow Health Inc
NASDAQ:HROW
Average P/E: 33.4
Negative Multiple: -46.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A
EV/EBIT Multiple
EBIT Growth
US
Harrow Health Inc
NASDAQ:HROW
Average EV/EBIT: 2 079.6
Negative Multiple: -239.4
14 361%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A
US
Eli Lilly and Co
NYSE:LLY
54.5
212%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
DK
Novo Nordisk A/S
CSE:NOVO B
27.8
85%
US
Johnson & Johnson
NYSE:JNJ
15.8
29%
US
Merck & Co Inc
NYSE:MRK
12.5
695%
CH
Roche Holding AG
SIX:ROG
12.1
27%
CH
Novartis AG
SIX:NOVN
14.9
54%
UK
AstraZeneca PLC
LSE:AZN
253.7
131%
IE
E
Endo International PLC
LSE:0Y5F
622.6
N/A

See Also

Discover More
Back to Top